Study finds underutilization of fidaxomicin, a recommended treatment for C. diff infection, despite increased use in hospitals.

Updated guidelines recommend fidaxomicin as the first-line agent for C difficile infection, but researchers found use in US ...

C. difficile spores are highly resistant to desiccation, chemicals and extreme temperature. Spores frequently contaminate the environment around patients with CDI, potentially persisting for ...

Therefore, new therapeutic or strategies already available for treatment of CDI have two goals: eradicating the infection, despite the continuation of concomitant therapy, and reducing the ...

Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...

H. pylori infections occur across the world due to exposure to saliva or stool in contaminated water or food. Learn how the ...

This is the reality for nearly 500,000 Americans each year who have the bacterial infection known as Clostridioides ... Hospitals try to prevent C diff. among patients in several ways.

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

After using her brother as a donor, Koepke reported that her symptoms got better, amazingly she started developing acne like ...

She led CDC activities to detect and prevent infections in healthcare settings, like C. diff, and promote healthcare safety in the United States and worldwide. Before her tenure at the CDC ...